PUBLIC COMPANY
save$SANASana Biotechnology, Inc.
$SANA3.5500-3.27%Seattle, WA, USupdated 8h ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
5
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
Recent(90d)
earnings (1)
Insider activity
source: SEC Form 4routine RSU / option mechanics (6)
- Apr 6, 26grantBishop Hans Edgar · 7,763 sh
- Mar 9, 26tax coverHarr Steve · President & CEO12,819 sh
- Mar 9, 26tax coverHarr Steve · President & CEO11,526 sh
- Mar 9, 26tax coverWyrick Susan D. · See Remarks3,342 sh
- Mar 9, 26tax coverWyrick Susan D. · See Remarks1,045 sh
- Mar 7, 26option exerciseHarr Steve · President & CEO50,000 sh
🐶 Hiring Signal
next earnings Nov 5, 2026
Where Sana Biotechnology, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaMetabolic 2
News
- Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceAfter the trailblazing approval of Sanofi’s Tzield for stage 3 type 1 diabetes, several companies, including SAB Biotherapeutics and Eledon Pharmaceuticals, are vying for a spot in the landscape wi…biospace · 26d ago
- Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this storyAn oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.stat · 2mo ago
Data sources
last refreshed 11m ago
Found something off?
comments(0)
5-min edit window · permanent after that